 |
BioWorld-International-2007-09-19
NeuroSearch Shares Boosted By Tesofensine Obesity Data
NeuroSearch Shares Boosted By Tesofensine Obesity Data
Shares in NeuroSearch A/S gained almost 22 percent Monday on news that its candidate obesity drug tesofensine attained an average weight reduction of about 10 ten percent in a Phase IIb clinical trial. (BioWorld International)